Biopharmaceutical Company Rigvir Group has assigned one of its holding
organizations to a new partner - the Global Virotherapy Cancer Clinic of
Virotherapy Excellence. This is implemented as a part of the strategy to
focus all the resources exclusively on the biotech format of the company,
continuing extensive research and development of its main product, the
oncological virus Rigvir, and novel product indications.
The clinics new owner, the Amber Capital holding, will continue the work under the name "Global Virotherapy and Integrative Medicine Cancer Clinic". "Cancer virotherapy is a treatment method we believe in, so it was a significant argument to acquire this company. We will continue to build this clinic as a place where oncological patients from all over the world can expect their physical and psychological health to be taken care of according to the highest standards of medical service," emphasizes the new head of the clinic, Māris Lūks.
The clinic is in Jūrmala, Jaunā Street 12, offering patients with effective and complex treatment of cancer with virotherapy; In the new format, it is planned to supplement its range of services with several other medical methods available in Latvia and the necessary medical support measures for patients.
Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE
+ 44 20 38 684 002 (UK, London)
+ 1 646 88 33 419 (USA, New York)
+ 371 67 229 599 (Latvia)
© 2019 International Virotherapy Center Limited. All Rights Reserved
Ltd State of Well (Reg.Nr. 40203172199) on a base of Licence and Cooperation Agreement (No. IVC-SW-02.01.2019), signed January 2nd, 2019 is legally responsible for the content of the website www.virotherapy.eu